IOM Flags Top 100 Comparative Effectiveness Research Priorities; Drugs Mentioned Rarely
This article was originally published in The Pink Sheet Daily
Executive Summary
Among the top 25 priority CER topics, only five specifically mention including pharma or biotech products in the studies.
You may also be interested in...
PCORI To Solicit More Head-To-Head Comparative Studies
The Patient-Centered Outcomes Research Institute announces plans to encourage the submission of more proposals for head-to-head clinical comparative effectiveness studies. Among the research topics the institute will encourage are the Institute of Medicine’s top 100 priorities and recommendations from America’s Health Insurance Plans.
CDC Issues $10 Million In Comparative Effectiveness Research Awards
When it comes to comparative effectiveness research, the Centers for Disease Control and Prevention typically are not at the forefront of government agencies conducting activities in this space
CDC Issues $10 Million In Comparative Effectiveness Research Awards
When it comes to comparative effectiveness research, the Centers for Disease Control and Prevention typically are not at the forefront of government agencies conducting activities in this space